FDA has issued its Enforcement Report for March 23, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.
The Office of the U.S. Trade Representative on March 23 announced the extension of 352 exclusions from Section 301 tariffs on China. The exclusions, all of which had expired, resume effect as of Oct. 12, 2021, and will remain in effect through Dec. 31, 2022, USTR said.
FDA has issued its Enforcement Report for March 16, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.
FDA has issued its Enforcement Report for March 9, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.
FDA has issued its Enforcement Report for March 2, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.
FDA has issued its Enforcement Report for Feb. 23, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.
FDA has issued its Enforcement Report for Feb. 16, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.
The Animal and Plant Health Inspection Service on Feb. 11 suspended avocado export program operations in the Mexican state of Michoacan, after a “security incident” that included a verbal threat to an APHIS employee, an agency spokesperson emailed Feb. 14. “The suspension will remain in place for as long as necessary to ensure the appropriate actions are taken, to secure the safety of APHIS personnel working in Mexico,” the spokesperson said.
FDA has issued its Enforcement Report for Feb. 9, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.
FDA plans to begin a pilot in 2022 on unannounced foreign inspections of foreign drug facilities, in response to concerns that facilities in China and India are able to fix problems before announced inspections to evade FDA enforcement, according to a GAO report released Feb. 7. Likewise, the agency also will soon run a pilot on use of independent translators for inspections in China and Hong Kong, rather than relying on translators provided by the inspected facility.